Tag: cell therapy


  • KAIST Scientists Wake Sleeping Immune Cells to Attack Cancer: A Major Leap in Immunotherapy

    KAIST Scientists Wake Sleeping Immune Cells to Attack Cancer: A Major Leap in Immunotherapy

    Groundbreaking Approach: Awakening Dormant Immune Cells Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have unveiled a pioneering technique that reactivates the body’s own dormant immune cells to target and destroy cancer cells. This approach aims to simplify cancer immunotherapy by leveraging the patient’s existing immune system, potentially reducing the need for…

  • Engineered Dendritic Cells Harness Tumor EVs to Boost Cancer Immunotherapy

    Engineered Dendritic Cells Harness Tumor EVs to Boost Cancer Immunotherapy

    Unlocking a New Layer of Cancer Immunotherapy Immunotherapy has transformed cancer care by reprogramming a patient’s own immune system to recognize and destroy malignant cells. Yet many tumors deploy stealth tactics that dull the scanning power of dendritic cells, the immune system’s sentinels. Recent advances in cellular engineering, however, are turning the tables. Researchers are…

  • Biomaterial Scaffold Brings Regenerative Dentistry Closer to Growing Real Teeth

    Biomaterial Scaffold Brings Regenerative Dentistry Closer to Growing Real Teeth

    Regrowing Teeth: A New Frontier in Dentistry Tooth decay and loss have long relied on fillings, crowns, implants, and dentures. But a cutting-edge development in regenerative dentistry suggests a future where teeth could be grown biologically from the inside, using a specially engineered biomaterial scaffold. Scientists are exploring how this scaffold guides stem or progenitor…

  • Resolution Therapeutics Announces Regenerative Macrophage Therapy Data for Cirrhosis at AASLD 2025

    Resolution Therapeutics Announces Regenerative Macrophage Therapy Data for Cirrhosis at AASLD 2025

    Overview: New Data Spotlight Regenerative Macrophage Therapy Resolution Therapeutics has announced key updates from its ongoing research into Regenerative Macrophage Therapy (RMT) for cirrhosis, with fresh data presented at AASLD 2025. The company highlighted early signals from the MATCH Phase II study showing that patients receiving non-engineered macrophages exhibit early improvements in liver function. In…

  • Lab-grown Embryo Model Produces Blood Cells for Therapy

    Lab-grown Embryo Model Produces Blood Cells for Therapy

    Breakthrough: Lab-grown embryo-like structures form blood progenitors Researchers have created embryo-like structures from human stem cells in the laboratory that spontaneously generate blood cells. This milestone could one day enable bone marrow–related therapies using a patient’s own cells, reducing the risk of immune rejection and expanding treatment options for blood disorders. How the model works…

  • Knut Steffensen Leads Karolinska ATMP Center to Bring Therapies to Patients

    Knut Steffensen Leads Karolinska ATMP Center to Bring Therapies to Patients

    Moving cell and gene therapy from lab to patient care The Karolinska Institutet is establishing a dedicated ATMP Center to accelerate the development of advanced therapy medicinal products (ATMPs) and to close the gaps between discovery, manufacturing, and clinical delivery. Led by Knut Steffensen, the center aims to function as a “virtual hub” where researchers,…

  • ATMP Centre at Karolinska: Bridging Cell & Gene Therapy

    ATMP Centre at Karolinska: Bridging Cell & Gene Therapy

    From Lab to Patient: The Mission of Karolinska ATMP Centre Knut Steffensen leads a bold effort to move cell and gene therapies from research benches to patient care. The ATMP Centre at Karolinska Institutet aims to shorten the distance between discovery, manufacturing, and clinical application, turning a once sci fi dream into everyday medicine. The…

  • Knut Steffensen Drives Cell and Gene Therapy From Lab to Patients at Karolinska

    Knut Steffensen Drives Cell and Gene Therapy From Lab to Patients at Karolinska

    From Lab to Patient: Turning Cell and Gene Therapy into Real Treatments Knut Steffensen is taking on the ambitious task of steering cell- and gene-based therapies from the research bench into routine patient care at Karolinska. As head of the university’s ATMP-Centre, he faces the challenge of coordinating the many moving parts required to translate…